Site/Sponsor Relationships
Q&A Part II: Clinical Trial Feasibility: Ensuring Success for Clinical Sites
Part 2 of Q&A from the Clinical Trial Feasibility: Ensuring Success for Clinical Sites webinar outlining why it is important for sites to approach research operations as a business.
Q&A Part I: Clinical Trial Feasibility: Ensuring Success for Clinical Sites
Q&A from the Clinical Trial Feasibility: Ensuring Success for Clinical Sites webinar outlining why it is important for sites to approach research operations as a business.
Insights Accrual Prediction Platform Leverages Machine Learning to Advance Better Research
The ability to accurately predict accrual to a protocol before it’s activated can be hard, so Advarra has released the Insights Accrual Prediction platform.
To Be Patient-centric, Be Site-centric
What does it mean to be “site-centric” as a step toward patient centricity? Patient centricity has long been a key goal in healthcare, as well as in clinical research. Read our latest blog on what it means to be site-centric as a step toward patient centricity.
James Riddle and Luke Gelinas Explore Digital Health and Regulation
This podcast covers an array of topics as they explore how COVID has been a catalyst for change, what digital health means for running clinical trials, and how sponsors, CROs, sites, and IRBs can consider when reviewing new digital technologies as a result of COVID.
Building Remote Workflows within eRegulatory Document Management: Subject Binders & SOPs
Advarra eRegulatory Management System now supports the storage and remote monitoring of Subject Binders and SOPs, increasing compliance, and centralizing your study documents.
Clinical Trial Feasibility: Ensuring Success for Clinical Sites
With comprehensive research portfolios and a myriad of operational challenges to manage, it has never been more important for sites to approach research operations as a business.
4 Reasons Your Institution Needs an eRegulatory System
Using physical binders or an internal shared drive can slow research operations. Implementing an eRegulatory system helps institutions streamline research by transforming key workflows.
Q&A: Institutional Responsibilities Under a Federalwide Assurance
Q&A from the Institutional Responsibilities Under a Federalwide Assurance (FWA) webinar and an overview of the FWA and its changes with the revised Common Rule.
Understanding the Complexity and Uniqueness of Phase I Trials
There are many distinctions that set Phase I trials apart from the rest. For sites aiming for a successful Phase I trial, working with an organization that understands the nuances is key.